This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: Pfizer Corporation, University of California, Leland Stanford Junior University. Active years: 2018-2026.
Company Filing History:
5 out of 4,486 
4 out of 15,988 
3 out of 5,497 
Years Active: 2018-2026
Title: Eleonora Trotta: Innovator in Immunology
Introduction
Eleonora Trotta is a prominent inventor based in San Francisco, CA, known for her significant contributions to the field of immunology. With a total of four patents to her name, she has made remarkable strides in developing therapeutic methods for immune-related diseases.
Latest Patents
Trotta's latest patents include innovative approaches to treating CD2-mediated immune diseases. One of her notable inventions is the Lymphocyte function-associated antigen 3 (LFA3) variant polypeptides and methods of use thereof. This invention provides LFA3 polypeptide molecules, including variant LFA3 fusion polypeptide molecules, along with associated methods for their application. Another significant patent is focused on Anti-IL-2 antibodies and their compositions. This invention offers antibodies that specifically bind to IL-2, reducing its affinity for IL-2 receptors. The therapeutic methods associated with this invention aim to treat and prevent autoimmune diseases and disorders.
Career Highlights
Throughout her career, Trotta has worked with esteemed organizations such as the University of California and Pfizer Corporation. Her work in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Natasha K Crellin and Jeffrey A Bluestone, who have also made significant contributions to immunology.
Conclusion
Eleonora Trotta's innovative work in immunology and her patents reflect her dedication to advancing medical science. Her contributions are paving the way for new treatments and therapies in the field of immune diseases.